Skip to content

Quebec · Registered charity

Institut du cancer de montréal / Montréal Cancer Institute

Institut du cancer de montréal / Montréal Cancer Institute (Quebec) receives grants from 91 organizations whose Canada Revenue Agency filings report C$7,139,137 to it, the largest being SOCIÉTÉ DE RECHERCHE SUR LE CANCER/CANCER RESEARCH SOCIETY (C$2,175,136). 57 of them have funded it in more than one year.

Revenue FY2024
C$4.0M
Funders on record
91
Grants received
C$7.1M
Net assets
C$16M
57/91 repeat funderspeak grant-dependency 37%
01What it does

What Institut du cancer de montréal / Montréal Cancer Institute does

Ongoing programs

Paiement au chum( axe d'oncologie du centre de recherche)de montants servant à des bourses de recherche. Paiement dans le cadre du progamme de subvention de recherche rené malo servant à appuyer la recherche novatrice sur le cancer. Organisation de diverses activitiés de levées de fonds pour amasser des dons pour les fonds sur la recherche sur le cancer de la prostate le cancer de l'ovaire en oncologie thoracique et en immuno-thérapie.

As stated on its FY2024 T3010.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 (C$3.1M) Expenses 100 (C$1.9M) Net assets 100 (C$12M)2018 Revenue 102 (C$3.1M) Expenses 162 (C$3.1M) Net assets 100 (C$12M)2019 Revenue 135 (C$4.1M) Expenses 149 (C$2.9M) Net assets 110 (C$13M)2020 Revenue 76 (C$2.3M) Expenses 118 (C$2.3M) Net assets 112 (C$13M)2021 Revenue 131 (C$4.0M) Expenses 91 (C$1.8M) Net assets 130 (C$16M)2022 Revenue 98 (C$3.0M) Expenses 144 (C$2.8M) Net assets 132 (C$16M)2023 Revenue 111 (C$3.4M) Expenses 145 (C$2.8M) Net assets 137 (C$17M)2024 Revenue 130 (C$4.0M) Expenses 213 (C$4.1M) Net assets 136 (C$16M)
'17'18'19'20'21'22'23'24
Revenue (130)Expenses (213)Net assets (136)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from C$15M to C$16M (+12%).

C$12M
C$12M
C$14M
C$15M
C$16M
C$17M
C$17M
C$17M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

64% of Institut du cancer de montréal / Montréal Cancer Institute’s revenue is contributions — more reliant on donations than three-quarters of its peers (6% for the typical peer).

This organization
Typical peer · 815 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 8 reported years ran a deficit.

C$1.1M
’17
−C$12k
’18
C$1.3M
’19
C$53k
’20
C$2.2M
’21
C$221k
’22
C$609k
’23
−C$130k
’24
2.1
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

'17'18'19'20'21'22'23'24
Listed1416202215161621
Joined·+3+5+4+1+1+1+6
No longer listed·1128011
03Who funds it

Who funds it, year by year

2017 → 2023: the base narrowed from 36 funders to 20 funders, grant income rose C$594k → C$1.1M.

Funder
'17
'18
'19
'20
'21
'22
'23
'24*
total
C$175k
C$102k
C$100k
C$61k
C$50k
C$39k
C$30k
C$15k
C$12k
funders
36
37
41
28
28
32
20
27

From the CRA filings of Institut du cancer de montréal / Montréal Cancer Institute’s funders (the co-funder graph). Top 30 of 91 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.

How concentrated its funding is

Institut du cancer de montréal / Montréal Cancer Institute leans on a few funders — its largest provides 30% of grant income and the top three 61%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Institut du cancer de montréal / Montréal Cancer Institute.

30%
largest funder
61%
top three
~6
effective funders

Largest funder’s share by year: 2017 29% · 2018 24% · 2019 36% · 2020 27% · 2021 39% · 2022 58% · 2023 45% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.

How long its funders stay

32% of Institut du cancer de montréal / Montréal Cancer Institute's funders are still giving 3 years after their first grant; 63% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

69% of Institut du cancer de montréal / Montréal Cancer Institute's grant income comes from Quebec funders.

In-province vs out-of-province, by year

’17
’18
’19
’20
’21
’22
’23
Quebec out of province

Funder regions come from each funder’s own filing. C$822k arriving through sponsors registered in 2 regions is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.

04Its place in the field

Against its field

Institut du cancer de montréal / Montréal Cancer Institute's funding has concentrated — grant income rose while the number of funders held roughly flat.

Operating margin−3% · bottom quartile
Months of reserve2.1mo · below the median
Revenue growth (annualized)4% · below the median

this organization peer median middle 50% of peers· 879 core health care nonprofits $1M–$10M, FY2024

Organizations like Institut du cancer de montréal / Montréal Cancer Institute

Organizations whose mission and program text most resemble this one, by semantic similarity over every charity on the CRA register — the closest peers, and often the clearest route to shared or prospective funders.

In Quebec

Nationally

05Profile & governance

Read directly from this organization’s own T3010 return, as neutral context.

Where the money goes

63% of spending goes to programs.

Program 63%Management 16%Fundraising 21%

Governance

21
board members

Questions and answers

Who funds Institut du cancer de montréal / Montréal Cancer Institute?
Institut du cancer de montréal / Montréal Cancer Institute (Quebec) receives grants from 91 organizations whose Canada Revenue Agency filings report C$7,139,137 to it, the largest being SOCIÉTÉ DE RECHERCHE SUR LE CANCER/CANCER RESEARCH SOCIETY (C$2,175,136). 57 of them have funded it in more than one year.
How many funders does Institut du cancer de montréal / Montréal Cancer Institute have?
Canada Revenue Agency filings report 91 organizations giving C$7,139,137 in grants to Institut du cancer de montréal / Montréal Cancer Institute, 57 of which have funded it in more than one year.
Who is the largest funder of Institut du cancer de montréal / Montréal Cancer Institute?
SOCIÉTÉ DE RECHERCHE SUR LE CANCER/CANCER RESEARCH SOCIETY is the largest funder on record, with C$2,175,136 in grants. The full list of funders is on this page.
How can an organization like Institut du cancer de montréal / Montréal Cancer Institute find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Quebec.

These figures are read directly from the CRA's published T3010 data: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 91 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · View the T3010 on the CRA register